Copper ion load from AHK-Cu remains well below toxic thresholds even at 2mg daily, but chronic use beyond 6 months lacks human safety data as of 2026
Dietary folate deficiencies and drugs that interfere with folate metabolism, eg, methotrexate, an anti-carcinogenic agent that inhibits dihydrofolate reductase, and nitrous dioxide (N 2 O), an anesthetic gas that inhibits methionine synthase activity, lead to accumulations and cellular effluxes of homocysteine, causing increases in circulating homocysteine levels (Ueland and Refsum, 1989)
Neuroprotective & Cognitive Effects: Animal studies indicate DSIP promotes neuroprotection and cognitive health by enhancing mitochondrial function and reducing oxidative stress
In addition to commonly used iron chelating therapy, regulating hepcidin levels may also help alleviate iron overload in -thalassemia patients, due to their typically low hepcidin levels
Concordantly, we found that most of the metaphases in WT as well as in ADH5 cells were normal and only few of them presented chromosome damage
Safety, Tolerability & Regulatory Status Safety Profile GHK-Cu demonstrates an excellent safety profile for cosmetic use: Naturally occurring in humans (plasma, saliva, urine) Non-sensitizing in standard patch testing at cosmetic concentrations Long history of topical application in anti-aging and wound care products Minimal reported adverse reactions at appropriate doses Usage Levels and Tolerability Regulatory Status EU : Permitted as a cosmetic ingredient with standard safety assessments US/Asia-Pacific : Allowed under respective cosmetic regulations Formulators must : Perform product-specific safety evaluations, including SDS review, toxicological profiles, and margin of safety calculations Addressing Copper Uglies Literature occasionally references theoretical over-stimulation of MMPs leading to collagen breakdown (sometimes called copper uglies)
